Cyclacel Pharma ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Momentum Movers Trading Halts

Pre-Open Movers 04/04: (GNCMA) (PRTK) (CYCC) Higher; (AYI) (KATE) (NVDA) Lower (more...)April 4, 2017 9:29 AM Cyclacel Pharma (CYCC) Continues Monday's Surge Following Preclinical Anti-Cancer Data; Gains Another 40%April 4, 2017 8:13 AM Cyclacel Pharma (CYCC) Surges Following Preclinical Data on CYC065April 3, 2017 10:09 AM Cyclacel Pharma (CYCC) Halted on LUDPApril 3, 2017 9:57 AM Cyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Elicits Marked Antineoplastic Effects in Lung Cancer by Engaging Anti-Metastatic PathwaysApril 2, 2017 1:00 PM